Evolent Health (EVH) Current Deferred Revenue (2015 - 2026)

Evolent Health has reported Current Deferred Revenue for 12 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Deferred Revenue fell 71.76% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 71.76% YoY), and the FY2025 full-year result was $1.2 million, down 52.01% from the prior year.
• Current Deferred Revenue for Q1 2026 stood at $1.4 million, up from $1.2 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $13.3 million in Q1 2022, with the low at $1.2 million in Q4 2025.
• Average Current Deferred Revenue over 5 years is $5.9 million, with a median of $5.8 million recorded in 2022.
• Year-over-year, Current Deferred Revenue climbed 3.79% in 2023 and slumped 71.76% in 2026.
• Tracing EVH's Current Deferred Revenue over 5 years: stood at $5.8 million in 2022, then increased by 3.79% to $6.0 million in 2023, then slumped by 58.05% to $2.5 million in 2024, then plunged by 52.01% to $1.2 million in 2025, then climbed by 17.79% to $1.4 million in 2026.
• The last three Current Deferred Revenue figures came in at $1.4 million (Q1 2026), $1.2 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.

Peer Comparison